期刊文献+

氟伐他汀对慢性心力衰竭患者心功能及标志物的影响

Effect of Fluorine on chronic heart failure patients with cardiac function and markers
下载PDF
导出
摘要 目的:观察氟伐他汀短期应用对慢性心力衰竭(CHF)患者心功能[左室射血分数(LVEF)]、B型尿钠肽(BNP)、丙二醛的影响。方法:入选2008年1月至2009年1月在我院收治的CHF住院患者80例,男48例,女32例,年龄35~72(62±9)岁,按NYHA分级(Ⅱ~Ⅲ级)随机分成治疗组(n=40例)和对照组(n=40例)。治疗组在对照组的基础上加用氟伐他汀80 mg,共12周。治疗前后检查心脏超声,评估心功能,侧定BNP、丙二醛和血脂水平。结果:12周后,治疗组总胆固醇[(4.0±0.5)比(4.5±0.8)mmol/L,P<0.05]、三酰甘油[(1.3±0.6)比(1.5±0.5)mmol/L,P<0.05)]、低密度脂蛋白胆固醇[LDL-C,(2.1±0.4)比(2.5±0.6)mmol/L,P<0.05]较对照组明显降低,差异具有统计学意义。与治疗前比较,两组LVEF有明显改善,治疗组较对照组改善更明显[(55.4%±5.2%)比(46.4%±4.5%),P<0.05];且BNP水平治疗后有明显降低,治疗组较对照组更为明显[(203.1±45.1)比(301.2±50.3)ng/L;丙二醛(4.8±1.8)比(7.7±1.1)gmol/L;P<0.05]。结论:氟伐他汀短期应用能改善心脏功能,减少心肌细胞损害,有益于慢性心力衰竭的治疗。 Objective:To observe the effect of short-term application of Fluvastatin on cardiac function(left ventricular ejection fractions,LVEF),Brain natriuretic peptide(BNP) and malondialdehyde(MDA) in patients with chronic heart failure(CHF).Methods:80 cases who admitted to our hospital for CHF(NYHA grade Ⅱ-Ⅲ grade) form Jan,2008 to Jan,2009 were randomly divided into treatment group(n = 40 cases) and control'group(n = 40 cases).Among all teases patients,age 35~72(62±9)years,48 were male and 32 were female.Treatment group was given Fluvastatin 80mg for 12 weeks compared with control group.by doing cardiacul trasound examination to evaluate the treatment.The results were evaluated by doing Doppler-Echocardiography examination,assessing cardiac function,and Monitoring the level of BNP,MDA and lipid before and after treatment.Results: After 12 weeks of treatment,we compared treatment group with control group,the results showed that the indices which included the total cholestero(4.0±0.5mmol/L VS 4.5±0.8 mmol/L,P0.05),triglyeride(1.3±0.6mmol/L VS 4.51.5 ±0.5 mmol/L,P0.05),low density lipoprotein-cholesterol(LDL-C,2.1±0.4mmol/L VS 2.5±0.6 mmol/L,P0.05) were decreased markedly.The indices which included the cardiac function(according to NYHA classification) and left ventricular ejection fraction were improved both in treatment group and control group after treatment,however,the indices of the treatment group were improved markedly compared with control group [LVEF(55.4%±5.2% VS 46.4%±4.5%,P0.05)];The indices which included the level of BNP and MDA were decreased both in treatment group and control group after treatment,but it was more decreased significantly in the treatment group compared with control group [BNP(203.12±45.12ng/L VS 301.23±50.34 ng/L);MDA(4.78±1.82 gmol/L VS 7.68±1.12 gmol/L);P0.05)].Conclusions: Short-term application of Fluvastatin can improve heart function,reduce myocardial cell damage and is wholesome for the treatment of chronic heart failure.
作者 王海明
出处 《中国民康医学》 2011年第21期2641-2643,2647,共4页 Medical Journal of Chinese People’s Health
关键词 氟伐他汀 慢性心力衰竭 B型尿钠肽 丙二醛 Fluvastatin Cardiac failure Brain natriuretic peptide Malondialdehyde
  • 相关文献

参考文献9

  • 1Ray JC, Gong Y, Sgkora K, et al. Statin use and survival outcomes in elderly patients with heart failure[ J]. Arch Intern Med ,2005, 165(6) :62 -67.
  • 2Rainer U, Pliqiuent MD, Kurtos G, et al. Simvastatin normalizers autonomic neural control in experimental heart failure[ J ]. Circu- lation,2003,107 ( 8 ) :2493 - 2498.
  • 3陆再英,钟南山,谢毅,等.内科学[M]//陆再英.心力衰竭.第7版.北京:人民卫生出版社,2007:131-132.
  • 4Ferro D , Parrotto S , Basili S , et al. Simvastatin inhibits the mono- cyte expression of porinflammatory cytokines in patients with hypercholesteorlemia[ J ]. J Ama Coil Cardio1,2000,36 (2) :427.
  • 5杨兵生,王声愿.慢性心衰患者血浆中肿瘤坏死因子及白细胞介素-6水平的变化[J].苏州医学院学报,2000,20(9):817-818. 被引量:8
  • 6Ichihara S, Noda A, Nagata K, et al. Pravastatin increases survival and suppresses and increase in myocardial matrix metalloproteinase activity in a rat model of heart failure [ J ]. Cardiovasc Res ,2006, 69(4) :726 -735.
  • 7康立丽.脑钠肽在心力衰竭中的临床应用价值[J].吉林医学,2010,31(9):1235-1236. 被引量:11
  • 8刘晓方,吴辉.他汀类药物在慢性心力衰竭防治中的作用[J].中国实用内科杂志,2006,26(9):1353-1354. 被引量:21
  • 9Node K,Fujita M,Kitakaze M,et al. Short -term statin therap im-proves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy [ J ]. Circulation, 2003,108 ( 4 ) : 839 - 843.

二级参考文献14

  • 1王安才,成蓓,谢晓竟,徐浩.阿托伐他汀对自发性高血压大鼠心室重构的影响[J].中国临床药理学与治疗学,2004,9(8):880-884. 被引量:32
  • 2张冬颖,覃数.他汀类药物改善心室重塑的研究进展[J].重庆医学,2004,33(10):1581-1583. 被引量:17
  • 3蔡文阳,吴平彬,林育群,肖德明,林建华,陈海庆.辛伐他汀改善慢性心力衰竭预后的临床观察[J].中国实用内科杂志,2005,25(4):338-339. 被引量:14
  • 4Kragelung, C, Gronning, B, Kober, L, Hildebrandt, P and Steffensen, R, N-terminal pro-B-type natriuretic peptide and long- term mortality in stable coronary heart disease[J]. N Eenl J Med; 2005:352:666-75.
  • 5McCullough PA, Nowak RM, McCord J,et al. B-type natriuretic peptide and clinical judgement in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational study[J]. Circulation, 2002, 106: 416-422.
  • 6Morrison KL, Harrson A, Krishnaswamy P, et al. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in passients presenting with dyspnea[J]. An Coll Cardiol, 2002, 39:202-209.
  • 7Jortani SA Prabhu SD,Valdes RJ.Strategies for developingbiomarkers of heart failure[J].Clin Chem,2004,50:265-278.
  • 8Berger R, Huelsman M, Strecker K, et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure[J]. Circulation, 2002, 105:2392-2397.
  • 9Cowie MR. BNP: soon to become a roution measure in the care of patients with heart failure?[J]Hearg 2000,83:617-618.
  • 10Hegewish S,Lancet,1990年,294页

共引文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部